As part of another treatment strategy for cancer metabolism, most research have been concentrated inhibiting enzymes related to UMP synthesis, with a particular focus on drugs targeting DHODH (e.g., leflunomide) and CAD enzymes [28, 29]. This evidence concerns the gene DHODH and cancer.